Citadel (#555)
Laufzeit: 01.01.2016 - 31.12.2017
imported
Kurzfassung
A phase 2 open label study to investigate the efficacy of autologous EBV-specific T-cells for the treatment of patients with aggressive EBV positive extranodal NK/T-cell lymphoma (ENKTCL)
